Histogen Statistics
Total Valuation
Histogen has a market cap or net worth of 118,328. The enterprise value is -5.49 million.
| Market Cap | 118,328 |
| Enterprise Value | -5.49M |
Important Dates
The next estimated earnings date is Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Histogen has 4.27 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 4.27M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.85% |
| Owned by Institutions (%) | 0.00% |
| Float | 4.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.23 |
| PB Ratio | 0.02 |
| P/TBV Ratio | 0.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.44 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.54 |
Financial Position
The company has a current ratio of 4.05
| Current Ratio | 4.05 |
| Quick Ratio | 3.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -119.89% and return on invested capital (ROIC) is -59.46%.
| Return on Equity (ROE) | -119.89% |
| Return on Assets (ROA) | -53.81% |
| Return on Capital (ROIC) | -59.46% |
| Revenue Per Employee | 2,714 |
| Profits Per Employee | -1.77M |
| Employee Count | 7 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.06% in the last 52 weeks. The beta is 1.12, so Histogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -92.06% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 20.14 |
| Average Volume (20 Days) | 1,944 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.63 |
Income Statement
In the last 12 months, Histogen had revenue of 19,000 and -12.38 million in losses. Loss per share was -2.90.
| Revenue | 19,000 |
| Gross Profit | -3.26M |
| Operating Income | -12.06M |
| Pretax Income | -12.38M |
| Net Income | -12.38M |
| EBITDA | -11.92M |
| EBIT | -12.06M |
| Loss Per Share | -2.90 |
Balance Sheet
| Cash & Cash Equivalents | 4.57M |
| Total Debt | n/a |
| Net Cash | 4.57M |
| Net Cash Per Share | 1.07 |
| Equity (Book Value) | 4.40M |
| Book Value Per Share | 1.27 |
| Working Capital | 4.11M |
Cash Flow
In the last 12 months, operating cash flow was -10.07 million and capital expenditures -1,000, giving a free cash flow of -10.08 million.
| Operating Cash Flow | -10.07M |
| Capital Expenditures | -1,000 |
| Free Cash Flow | -10.08M |
| FCF Per Share | -2.36 |
Margins
| Gross Margin | n/a |
| Operating Margin | -63,447.37% |
| Pretax Margin | -65,173.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Histogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -59.75% |
| Shareholder Yield | -59.75% |
| Earnings Yield | -10,452.80% |
| FCF Yield | -8,514.49% |
Stock Splits
The last stock split was on June 3, 2022. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 3, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
Histogen has an Altman Z-Score of -27.9. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -27.9 |
| Piotroski F-Score | n/a |